KimeraChems.coUse code GUIDE for 10% OFF
Back to Peptides
Peptides

Cardiogen

Shop Cardiogen on KimeraChems · code GUIDE (10% off)

Definition

Cardiogen is a synthetic tetrapeptide bioregulator that has been studied for its effects on cardiac tissue regeneration, cellular aging, and tumor biology. What makes it mechanistically notable is its dual action in heart tissue: it simultaneously stimulates cardiomyocyte proliferation and suppresses apoptosis by reducing p53 protein expression, an effect not replicated by individual amino acids in comparative studies. This combination of growth stimulation and cell survival promotion positions it as a candidate for addressing age-related cardiac dysfunction, particularly given that its efficacy in experimental models remained consistent across both young and aged tissue where conventional regenerative approaches often lose effectiveness. Research has also explored its effects on prostate fibroblast aging and tumor growth modulation in sarcoma models, indicating a broader regulatory profile that extends beyond cardiac applications.

Mechanism of Action

  • Cardiomyocyte proliferation stimulation activating cardiac muscle cell growth in heart tissue cultures across both young and aged specimens, maintaining efficacy in older tissue where regenerative capacity is naturally diminished and where conventional amino acid treatments showed significantly reduced effect
  • p53 suppression and anti-apoptotic activity reducing expression of p53, a key regulator of programmed cell death, allowing cardiomyocytes to survive in conditions where they would otherwise undergo apoptosis, contributing to cardiac tissue preservation
  • Fibroblast-driven scar formation inhibition suppressing the fibroblast activity that drives scar tissue development following cardiac injury, helping to preserve functional myocardial architecture rather than replacing it with non-contractile scar tissue
  • Tumor vascular network disruption in sarcoma models working through a mechanism involving the tumor's vascular supply to induce hemorrhagic necrosis and enhanced apoptosis in tumor cells, producing dose-dependent inhibition of M-1 sarcoma growth without direct cytostatic activity
  • Fibroblast differentiation signaling restoration in aging prostate tissue enhancing expression of CXCL12, WEDC1, and ghrelin in senescent prostate fibroblasts, reversing age-related declines in these critical signaling factors that govern fibroblast differentiation and tissue maintenance

Areas of Investigation

  • Cardiac tissue regeneration support through the dual mechanism of cardiomyocyte proliferation and anti-apoptotic activity, providing a pathway for cardiac repair that remains functional in aged tissue where other regenerative approaches fall short
  • Prevention of post-injury cardiac fibrosis by inhibiting fibroblast-driven scar formation that reduces heart function following injury, helping to maintain contractile tissue over non-contractile scar tissue
  • Age-consistent efficacy with research demonstrating maintained performance in aged cardiac tissue, making Cardiogen particularly relevant for elderly populations where cardiac regenerative capacity is most compromised
  • Tumor growth modulation with dose-dependent inhibition of sarcoma growth in senescent rat models through vascular disruption and enhanced tumor cell apoptosis, suggesting potential applications in oncology research contexts
  • Prostate fibroblast aging reversal restoring the expression of key differentiation signals in senescent prostate fibroblasts, contributing to the broader geroprotective profile of the compound beyond its cardiac applications

Safety Profile

  • Favorable tolerability profile consistent with the short bioregulator peptide class, which are derived from naturally occurring amino acid sequences and generally well tolerated across research populations
  • Limited long-term human clinical data with research conducted primarily in tissue culture and animal models, warranting a conservative and informed approach to dosing until more comprehensive human safety data becomes available
  • Injection site reactions possible with subcutaneous administration, manageable with proper technique and consistent site rotation
Disclaimer

For educational purposes only. Not for human consumption.